Cancer Epidemiology
Volume 34, Issue 6 , Pages 659-666 , December 2010

Childhood cancer survival: A report from the United Kingdom Childhood Cancer Study

  • W. Thomas Johnston

      Affiliations

    • On behalf of the United Kingdom Childhood Cancer Study.
    • Corresponding Author InformationCorresponding author at: Epidemiology and Genetics Unit, Area 3, Seebohm Rowntree Building, Department of Health Sciences, University of York, YO10 5DD, United Kingdom. Tel.: +44 0 1904 321888; fax: +44 0 1904 321899.
    • ,
  • Tracy J. Lightfoot

      Affiliations

    • On behalf of the United Kingdom Childhood Cancer Study.
    • ,
  • Jill Simpson

      Affiliations

    • On behalf of the United Kingdom Childhood Cancer Study.
    • ,
  • Eve Roman

      Affiliations

    • On behalf of the United Kingdom Childhood Cancer Study.

,Accepted 30 June 2010.

References 

  1. Magnani C, Pastore G, Coebergh JW, et al. Trends in survival after childhood cancer in Europe, 1978–1997: report from the Automated Childhood Cancer Information System project (ACCIS). Eur J Cancer. 2006;42(13):1981–2005
  2. Gatta G, Capocaccia R, Stiller C, et al. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol. 2005;23(16):3742–3751
  3. Sankila R, Martos Jimenez MC, Miljus D, et al. Geographical comparison of cancer survival in European children (1988–1997) report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):1972–1980
  4. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010;
  5. Altekruse SF, Kosary CL, Krapcho M, et al. SEER cancer statistics review, 1975–2007. Bethesda, MD: National Cancer Institute; 2010;
  6. Ellison LF, Pogany L, Mery LS. Childhood and adolescent cancer survival: a period analysis of data from the Canadian Cancer Registry. Eur J Cancer. 2007;43(13):1967–1975
  7. Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, Stiller CA, Coebergh JW. Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer. 2006;42(13):2183–2190
  8. Bosetti C, Bertuccio P, Chatenoud L, et al. Childhood cancer mortality in Europe, 1970–2007. Eur J Cancer. 2010;46(2):384–394
  9. Magnani C, Aareleid T, Viscomi S, Pastore G, Berrino F. Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study. Eur J Cancer. 2001;37(6):711–721
  10. Silverman LB, Stevenson KE, O’Brien JE, et al. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000). Leukemia. 2010;24(2):320–334
  11. Stiller CA. Population based survival rates for childhood cancer in Britain, 1980–91. BMJ. 1994;309(6969):1612–1616
  12. Wayne AS, Reaman GH, Helman LJ. Progress in the curative treatment of childhood hematologic malignancies. J Natl Cancer Inst. 2008;100(18):1271–1273
  13. Prados MD, Berger MS, Wilson CB. Primary central nervous system tumors: advances in knowledge and treatment. CA Cancer J Clin. 1998;48(6):331–60, 321
  14. Hann IM, Stevens RF, Goldstone AH, et al. Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood. 1997;89(7):2311–2318
  15. Salzer WL, Devidas M, Carroll WL, et al. Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984–2001: a report from the children's oncology group. Leukemia. 2010;24(2):355–370
  16. Gaynon PS, Angiolillo AL, Carroll WL, et al. Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: a Children's Oncology Group Report. Leukemia. 2010;24(2):285–297
  17. Lannering B, Sandstrom PE, Holm S, et al. Classification, incidence and survival analyses of children with CNS tumours diagnosed in Sweden 1984–2005. Acta Paediatr. 2009;98(10):1620–1627
  18. Spix C, Pastore G, Sankila R, Stiller CA, Steliarova-Foucher E. Neuroblastoma incidence and survival in European children (1978–1997) report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2081–2091
  19. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3(3):203–216
  20. Coebergh JW, Reedijk AM, de VE, et al. Leukaemia incidence and survival in children and adolescents in Europe during 1978–1997, Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2019–2036
  21. Qaddoumi I, Sultan I, Gajjar A. Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database. Cancer. 2009;115(24):5761–5770
  22. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993;328(24):1725–1731
  23. Peris-Bonet R, Martinez-Garcia C, Lacour B, et al. Childhood central nervous system tumours—incidence and survival in Europe (1978–1997) report from Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2064–2080
  24. Douglas NM, Dockerty JD. Population-based survival of children in New Zealand diagnosed with cancer during 1990–1993. Eur J Cancer. 2005;41(11):1604–1609
  25. Villeneuve PJ, Raman S, Leclerc JM, et al. Survival rates among Canadian children and teenagers with cancer diagnosed between 1985 and 1988. Cancer Prev Control. 1998;2(1):15–22
  26. Izarzugaza MI, Steliarova-Foucher E, Martos MC, Zivkovic S. Non-Hodgkin's lymphoma incidence and survival in European children and adolescents (1978–1997) report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2050–2063
  27. Pui CH, Boyett JM, Relling MV, et al. Sex differences in prognosis for children with acute lymphoblastic leukemia. J Clin Oncol. 1999;17(3):818–824
  28. Clavel J, Steliarova-Foucher E, Berger C, Danon S, Valerianova Z. Hodgkin's disease incidence and survival in European children and adolescents (1978–1997) report from the Automated Cancer Information System project. Eur J Cancer. 2006;42(13):2037–2049
  29. UK Childhood Cancer Study Investigators . The United Kingdom Childhood Cancer Study: objectives, materials and methods. Br J Cancer. 2000;82(5):1073–1102
  30. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer. 2005;103(7):1457–1467
  31. SAS Institute Inc. . SAS/STAT user's guide version 9. Cary, NC: SAS Institute Inc.; 2008;
  32. Lin DY, Wei LJ, Ying Z. Checking the Cox model with cummulative sums of martingale based residuals. Biometrika. 1993;80(3):557–572
  33. Smith A, Lightfoot T, Simpson J, Roman E. Birth weight, sex and childhood cancer: a report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol. 2009;33(5):363–367
  34. Smith A, Roman E, Simpson J, et al. Childhood leukaemia and socioeconomic status: fact or artefact? A report from the United Kingdom Childhood Cancer Study (UKCCS). Int J Epidemiol. 2006;35(6):1504–1513
  35. Stiller CA, Pritchard J, Steliarova-Foucher E. Liver cancer in European children: incidence and survival, 1978–1997, Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2115–2123
  36. Stiller CA, Bielack SS, Jundt G, Steliarova-Foucher E. Bone tumours in European children and adolescents, 1978–1997, report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2124–2135
  37. Pastore G, Peris-Bonet R, Carli M, et al. Childhood soft tissue sarcomas incidence and survival in European children (1978–1997) report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2136–2149
  38. MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978–1997), report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2092–2102
  39. Pastore G, Znaor A, Spreafico F, et al. Malignant renal tumours incidence and survival in European children (1978–1997) report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2103–2114
  40. Kaatsch P, Rickert CH, Kuhl J, Schuz J, Michaelis J. Population-based epidemiologic data on brain tumors in German children. Cancer. 2001;92(12):3155–3164
  41. Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2328–2338
  42. Mitchell CD, Richards SM, Kinsey SE, et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol. 2005;129(6):734–745
  43. Roman E, Simpson J, Ansell P, et al. Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am J Epidemiol. 2007;165(5):496–504
  44. Ansell P, Johnston T, Simpson J, et al. Brain tumor signs and symptoms: analysis of primary health care records from the UKCCS. Pediatrics. 2010;125(1):112–119
  45. Lightfoot TJ, Johnston WT, Painter D, et al. Genetic variation in the folate metabolic pathway and risk of childhood leukemia. Blood. 2010;
  46. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41(9):1006–1010

PII: S1877-7821(10)00128-1

doi: 10.1016/j.canep.2010.06.020

Cancer Epidemiology
Volume 34, Issue 6 , Pages 659-666 , December 2010

Article Tools

* Image Usage & Resolution